Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Perrigo To Acquire Generic Derma Products | Contract Pharma

What are you searching for?

Sign in
Breaking News

Perrigo To Acquire Generic Derma Products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Perrigo Company has entered into a purchase agreement to acquire nine generic prescription dermatological products and four pipeline products from Glades Pharmaceuticals, Inc. for $56 million in cash plus other consideration for future R&D collaborations. The transaction is expected to close by the end of March.

Perrigo president and chief executive officer, Joe Papa, stated, “We have enhanced our existing U.S. product portfolio and future pipeline with this strategic acquisition, demonstrating our on-going commitment to the generic prescription dermatological space. We believe that these new and future products will expand our leadership position in this category. This acquisition is also an opportunity for us to improve returns on our existing asset base. We look to identify more such opportunities in the future.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters